Glaxosmithkline Pharmaceuticals consolidated net profit declines 84.79% in the September 2020 quarter
Sales decline 0.31% to Rs 879.32 crore
Net profit of Glaxosmithkline Pharmaceuticals declined 84.79% to Rs 76.47 crore in the quarter ended September 2020 as against Rs 502.75 crore during the previous quarter ended September 2019. Sales declined 0.31% to Rs 879.32 crore in the quarter ended September 2020 as against Rs 882.02 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales879.32882.02 0 OPM %23.3022.00 -PBDT213.02208.97 2 PBT191.06186.27 3 NP76.47502.75 -85Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 28 2020 | 5:35 PM IST